From: Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
Gene | Nomenclature (locus) | Known mutations/variants | Clinical features | Penetrance by age 80* |
---|---|---|---|---|
Autosomal dominant forms of PD | ||||
SNCA | PARK1 and PARK 4 | Missense mutations: A53T, A30P, E46K, G50D Duplications and triplications | YOPD, atypical and severe phenotypes depending on the specific mutation (i.e. triplications give a more severe phenotype) | probably high, > 90% for A53T, unknown for others |
LRRK2 | PARK8 | G2019S: a missense mutation which is a frequent determinant of familiar and sporadic PD R1441G, Y1699C, I2020T | Classical (late-onset) PD | G2019S: 25–74% |
GBA1 | – | Mutations in GBA1 gene (NM_000157.3), also associated with Gaucher disease: N370S, S2716, L444P GBA1 variants (not associated with Gaucher disease) | Classical PD but with a slightly earlier onset age, severe motor impairment and higher prevalence of dementia and RBD | N370S, S2716: low risk, 7.6% L444P: high risk, 11–29.7% |
Autosomal recessive forms of PD | ||||
Parkin | PARK2 | Â | YOPD | 100% |
PINK1 | PARK6 | Â | YOPD | 100% |
DJ-1 | PARK7 | Â | YOPD | 100% |